These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 167787)

  • 1. Comparative effects of alkylating agents and other anti-tumour agents on the intracellular level of adenosine 3',5'-monophosphate in Walker carcinoma.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1975 Jul; 24(13-14):1271-6. PubMed ID: 167787
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations in adenosine 3', 5'-monophosphate-binding protein in Walker carcinoma cells sensitive or resistant to alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1976 Aug; 25(16):1831-6. PubMed ID: 9089
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of alkylating agents on adenosine 3',5'-monophosphate metabolism in Walker carcinoma.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1976 Aug; 25(15):1793-7. PubMed ID: 182174
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of cyclic 3',5'-nucleotide phosphodiesterase-a possible mechanism of action of bifunctional alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1975 Jan; 24(2):211-7. PubMed ID: 163094
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of alkylating agents on the activity of adenosine 3',5'-monophosphate-dependent protein kinase in Walker carcinoma cells.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1976 Nov; 25(21):2365-70. PubMed ID: 187201
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclic nucleotide metabolism in Walker carcinoma cells resistant to alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1978 Mar; 27(6):947-52. PubMed ID: 207283
    [No Abstract]   [Full Text] [Related]  

  • 7. Guanosine 3',5'-monophosphate and the action of alkylating agents.
    Tisdale MJ; Phillips BJ
    Chem Biol Interact; 1977 Dec; 19(3):375-81. PubMed ID: 202413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of cyclic adenosine 3':5'-monophosphate phospodiesterase from Walker carcinoma sensitive and resistant to bifunctional alkylating agents.
    Tisdale MJ
    Biochim Biophys Acta; 1975 Jul; 397(1):134-43. PubMed ID: 238630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenylate cyclase, cyclic adenosin 3':5'-monophosphate phosphodiesterase, and regression of Walker 256 mammary carcinoma.
    Cho-Chung YS; Newcomer SF
    Cancer Res; 1977 Dec; 37(12):4493-9. PubMed ID: 200352
    [No Abstract]   [Full Text] [Related]  

  • 10. Adenosine 3',5'-monophosphate phosphodiesterase activity in experimental animal tumours which are either sensitive or resistant to bifunctional alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1975 Jan; 24(2):205-10. PubMed ID: 163093
    [No Abstract]   [Full Text] [Related]  

  • 11. Preferential cytotoxicity of some novel alkylating agents under hypoxic conditions.
    Frearson M; Lee JB; Zaidi KF
    Pharmacol Res Commun; 1979 Mar; 11(3):237-43. PubMed ID: 461490
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutagenic alkylating agents as growth inhibitors and carcinogens.
    Koller PC
    Mutat Res; 1969; 8(1):199-206. PubMed ID: 5796941
    [No Abstract]   [Full Text] [Related]  

  • 13. On the biological alkylating agents.
    Haddow A
    Perspect Biol Med; 1973; 16(4):503-24. PubMed ID: 4593768
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma membrane as target of alkylating agents.
    Grunicke H; Doppler W; Hofmann J; Lindner H; Maly K; Oberhuber H; Ringsdorf H; Roberts JJ
    Adv Enzyme Regul; 1985; 24():247-61. PubMed ID: 2940819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reductive activation of N-oxides to cause DNA strand breakage in cell lines in vitro.
    Cahill A; White IN
    Biochem Soc Trans; 1991 Apr; 19(2):127S. PubMed ID: 1909655
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of the toxicity and antitumour activity of alkylating drugs by steroids.
    Shepherd R; Harrap KR
    Br J Cancer; 1982 Mar; 45(3):413-20. PubMed ID: 7073935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased glutathione-S-transferase activity in a cell line with acquired resistance to nitrogen mustards.
    Wang AL; Tew KD
    Cancer Treat Rep; 1985 Jun; 69(6):677-82. PubMed ID: 4016771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,4-dinitro-5-ethyleneiminobenzamide (CB 1954): a potent and selective inhibitor of the growth of the Walker carcinoma 256.
    Cobb LM; Connors TA; Elson LA; Khan AH; Mitchley BC; Ross WC; Whisson ME
    Biochem Pharmacol; 1969 Jun; 18(6):1519-27. PubMed ID: 4307990
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of thymidylate synthetase of Walker carcinoma by chlorambucil. A possible mechanism of action.
    Srinivasan SK; Gupta VS; Howarth RE
    Biochem Pharmacol; 1977 Jun; 26(11):1027-32. PubMed ID: 880254
    [No Abstract]   [Full Text] [Related]  

  • 20. Enflurane and adenosine 3',5'-cyclic monophosphate metabolism in pancreatic islets.
    Ewart RB; Rusy BF; Bradford MW
    Anesth Analg; 1985 Jan; 64(1):18-22. PubMed ID: 2981488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.